Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 706 of 5804
-
New schizophrenia drug KarXT shows promise in Long-Term safety trial
Disease control CompletedThis is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in de novo subjects with Diagnostic and Statistical Manual-Fifth Edition (DSM-5) schizophrenia. In this OL study, all subjects will rec…
Phase: PHASE3 • Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company • Aim: Disease control
Last updated Jun 26, 2026 18:11 UTC
-
New combo shows promise for aggressive breast cancer
Disease control CompletedThis is a multicenter, randomized, 2 arm, open label, phase II study. It is designed to compare the efficacy and safety of abemaciclib combined with ET (letrozole or fulvestrant) versus a short course with induction chemotherapy with paclitaxel followed by maintenance therapy wit…
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Mobile clinic brings one-stop HIV and addiction care to those who inject drugs
Disease control CompletedThe purpose of this study is to determine the efficacy of using a mobile health delivery unit ("mobile unit") to deliver "one stop" integrated health services - particularly medication for opioid use disorder (MOUD) and medication for HIV treatment and prevention - to people who …
Phase: NA • Sponsor: HIV Prevention Trials Network • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo targets Tough-to-Treat cancers
Disease control OngoingBackground: Small cell lung cancer (SCLC) and high-grade neuroendocrine cancers (HGNEC) are aggressive neuroendocrine cancers. At first, SCLC and HGNEC respond to chemotherapy. But then they relapse quickly and become resistant to treatment. Researchers want to see if a combinat…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Affordable CAR-T breakthrough: academic therapy offers new hope for blood cancer patients
Disease control Recruiting nowChimeric antigen receptor (CAR) T-cell therapy has been the standard of care for relapsed/refractory large B-cell lymphomas (R/R LBCLs) since 2018. However, high cost of commercial products limits their application in real-world clinical practice. Academic approach to manufacturi…
Sponsor: N.N. Alexandrov National Cancer Centre • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New combo therapy aims to halt spread of nasopharyngeal cancer
Disease control Recruiting nowWe intend to compare the efficacy and safety of immunotherapy plus stereotactic body radiotherapy at oligometastatic lesions and immunotherapy alone among patients with oligometastatic nasopharyngeal carcinoma whose primary lesion has been well controlled after radical local-regi…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Inhaled treprostinil aims to slow IPF lung damage in major trial
Disease control CompletedStudy RIN-PF-301 is designed to evaluate the superiority of inhaled treprostinil against placebo for the change in absolute forced vital capacity (FVC) from baseline to Week 52.
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heart monitoring during lung cancer therapy may save lives
Disease control Recruiting nowThis is a prospective, randomized, controlled, multi-center phase III clinical trial that intends to evaluate the role of early cardiovascular intervention based on impedance cardiography in patients with locally advanced non-small cell lung cancer receiving radical radiochemothe…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo shot aims to reignite immune attack on tough melanoma
Disease control CompletedATLAS-IT-05 is an open-label, single-arm study in patients with advanced melanoma accessible for injections (cutaneous, subcutaneous, lymph node, or intramuscular tumors) and who have either exhausted treatment options or are not eligible for, suitable for, or willing to undergo …
Phase: PHASE2 • Sponsor: Lytix Biopharma AS • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Immunotherapy before standard treatment may boost survival in esophageal cancer
Disease control OngoingThe objective of this clinical trial is to determine whether the addition of immunotherapy combined with chemotherapy before chemoradiotherapy can increase the survival rate of patients with esophageal cancer. It will also assess the safety of this regimen. The primary questions …
Phase: PHASE3 • Sponsor: Jiangsu Cancer Institute & Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New shot may shield transplant patients from deadly immune attack
Prevention CompletedAcute graft-versus-host disease (aGVHD) is a potentially fatal complication after allogeneic hematopoietic cell transplantation (HCT), particularly for that with a HLA-mismatched donor. Abatacept has been demonstrated as a potent drug to reduce the risk of aGVHD, but the efficacy…
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated Jun 27, 2026 13:06 UTC
-
Could a magnetic helmet ease bladder pain? new study investigates
Symptom relief OngoingInterstitial Cystitis/Bladder Pain Syndrome (IC/BPS) is a common, chronic, and debilitating condition in women. Preliminary evidence suggests that IC/BPS pain can be reduced applying non-invasive repetitive transcranial magnetic stimulation (rTMS) to areas of the brain that regul…
Phase: NA • Sponsor: University of Southern California • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Nutty idea: early tree nut exposure may shield Peanut-Allergic babies
Prevention CompletedEarly and regular ingestion of the common allergens, peanut and egg has been shown to be an effective allergy prevention strategy. It is not clear whether this is also true of tree nut allergy. Current practice in many Australian allergy clinics for children with peanut allergy (…
Phase: PHASE3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
New drug combo aims to control myeloma without transplant
Disease control OngoingDaratumumab for first line treatment of transplant-ineligible myeloma patients followed by daratumumab re-treatment at first relapse (GMMG-DADA)
Phase: PHASE2 • Sponsor: University of Cologne • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Zapping the heart with radiation to stop deadly rhythms
Disease control Recruiting nowVentricular tachycardia (VT) contributes to over 350,000 sudden deaths each year in the US. Malignant VTs involve an electrical "short circuit" in the heart, formed by narrow channels of surviving tissue inside myocardial scar. Current treatment for VT consists of either implanta…
Phase: NA • Sponsor: John Sapp • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can we wake and kill sleeping breast cancer cells? new trial aims to find out
Disease control Recruiting nowThis clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are found to harbor disseminated tumor cells (DTCs) in the bone marrow after definitive surgery and standard…
Phase: PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Double transplant: kidney and bladder together for the first time
Disease control Recruiting nowThe purpose of this study is to establish if concomitant renal and vascularized urinary bladder allograft transplantation is feasible.
Phase: EARLY_PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New laser blood test aims to detect breast cancer earlier
Diagnosis OngoingThe purpose of this study is to validate the interest of broadband spectroscopy analysis (femto/attosecond by infrared laser) on liquid biopsies in breast cancer screening.
Phase: NA • Sponsor: Centre Jean Perrin • Aim: Diagnosis
Last updated Jun 26, 2026 16:47 UTC
-
New hope for ovarian cancer: drug may delay return of disease
Disease control OngoingThis is a Phase III, randomised, double-blind, placebo-controlled, multicentre, international study assessing the efficacy and safety of maintenance olaparib compared with placebo in BRCAwt participants with Stage III to IV high grade serous or endometroid ovarian cancer (includi…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New shot cuts dangerous fat levels in half
Disease control CompletedThe purpose of AROAPOC3-2001 is to evaluate the efficacy and safety of ARO-APOC3 in participants with severe hypertriglyceridemia. Participants will receive 2 subcutaneous injections of ARO-APOC3.
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC